We’re now part of the PerkinElmer family
In 2021, PerkinElmer, Inc. (NYSE: PKI) a global leader committed to innovating for a healthier world, acquired BioLegend. The acquisition, the largest in PerkinElmer’s history, expands the combined companies’ ability to provide new, innovative solutions to scientists. PerkinElmer’s broad life science platform and strong global infrastructure will help BioLegend continue to extend our mission of enabling our customers to do legendary discovery.
BioLegend’s career opportunities are now accessed through the PerkinElmer career site.